General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a pharmacist at computer imageJanuary 8 2018

The number of suspected drug reactions reported via the Yellow Card scheme in Wales rose 28% in 2016-17, with 2,330 reports made. This compares to 1,817 reports the previous year, and continues the upwards trend in reporting seen over the past four years.

The top ten drugs with the most reports associated with them were:

Drug No of associated reports 2015-16 No of associated reports 2016-17
rivaroxaban 107 121
dapagliflozin 49 120
Neisseria meningitidis preparations 18 92
apixaban 42 73
ramipril 29 44
canagliflozin 18 43
warfarin 23 43
amlodipine 27 42
omeprazole 25 38
sertraline 30 38

Data given in the Yellow Card Centre Wales Annual Report indicates there has been a significant increase in the number of reports coming from pharmacy and from patients. The report notes that the increase in the number of reports submitted by pharmacists was 456%, reports from community pharmacists increased by 133%, while reports from members of the public rose 44%.

However, “GP reporters remained the highest reporting group and an increase of 12% was seen in the number of reports submitted by GPs compared with the previous year.” GPs contributed 972 reports, 42% of the total received.

“The increase in the number of reports from GPs may be related to the continuation of Yellow Card reporting rates as a National Prescribing (reporting) Indicator in primary care and the integration of Yellow Card reporting into the clinical system support which is used in some practices,” says the report.

“The majority of reports from pharmacists originated from GP practice addresses and are therefore likely to have been submitted from those working as practice-based pharmacists.” Five had attended the Yellow Card Champion Training Day held in March 2017

Links:
All Wales Therapeutics & Toxicology Centre Yellow Card Centre Wales Annual Reports       
YCC Wales Annual Report 2016-2017      
MHRA Yellow Card site   

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...